Well….according to the release, there are 1.3 million people in Australia living with diabetes. If 10,000 of them take the test annually (that being less than 1% of the total) that equals $2.45 million per annum in gross revenue, which is more than what some on HotCopper are predicting as initial revenues.
So while it’s not ideal to launch without a reimbursement status, the numbers above would appear to be reasonably achievable I would have thought - that being less than 1% of the total diabetic population willing and able to self fund the cost of the test. Imagine the numbers if and when reimbursement is granted.
Ann: PromarkerD predictive test for DKD launched in Australia, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.010(2.70%) |
Mkt cap ! $58.86M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 37.0¢ | 35.5¢ | $89.35K | 246.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 99321 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 7502 | 1 |
View Market Depth
| Last trade - 15.58pm 16/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |